Tratamiento farmacológico del hipertiroidismo actualmente

Autores:: Seco Fernández, Ana Carmen
Jaimes Cienfuegos, Javier
Jaimes García, Javier

Tipo de recurso:: Article of journal

Fecha de publicación:: 2023

Institución:: Universidad Pedagógica y Tecnológica de Colombia

Repositorio:: RiUPTC: Repositorio Institucional UPTC

Idioma:

id	REPOUPTC2_76b8e3e6f891d335254b08d54bcdf0ef
oai_identifier_str	oai:repositorio.uptc.edu.co:001/21808
network_acronym_str	REPOUPTC2
network_name_str	RiUPTC: Repositorio Institucional UPTC
repository_id_str
dc.title.es-ES.fl_str_mv	Tratamiento farmacológico del hipertiroidismo actualmente
title	Tratamiento farmacológico del hipertiroidismo actualmente
spellingShingle	Tratamiento farmacológico del hipertiroidismo actualmente Hipertiroidismo Tratamiento Enfermedad de Graves Hyperthyroidism Treatment Graves’ disease
title_short	Tratamiento farmacológico del hipertiroidismo actualmente
title_full	Tratamiento farmacológico del hipertiroidismo actualmente
title_fullStr	Tratamiento farmacológico del hipertiroidismo actualmente
title_full_unstemmed	Tratamiento farmacológico del hipertiroidismo actualmente
title_sort	Tratamiento farmacológico del hipertiroidismo actualmente
dc.creator.fl_str_mv	Seco Fernández, Ana Carmen Jaimes Cienfuegos, Javier Jaimes García, Javier
dc.contributor.author.spa.fl_str_mv	Seco Fernández, Ana Carmen Jaimes Cienfuegos, Javier Jaimes García, Javier
dc.subject.none.fl_str_mv	Hipertiroidismo Tratamiento Enfermedad de Graves Hyperthyroidism Treatment Graves’ disease
topic	Hipertiroidismo Tratamiento Enfermedad de Graves Hyperthyroidism Treatment Graves’ disease
publishDate	2023
dc.date.accessioned.none.fl_str_mv	2023-08-09 00:00:00 2026-04-16T17:52:22Z
dc.date.available.none.fl_str_mv	2023-08-09 00:00:00
dc.date.issued.none.fl_str_mv	2023-08-09
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.none.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv	info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv	Journal article
dc.type.version.none.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.none.fl_str_mv	Text
dc.type.coarversion.none.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	2389-8038
dc.identifier.uri.none.fl_str_mv	https://repositorio.uptc.edu.co/handle/001/21808
dc.identifier.doi.none.fl_str_mv	10.19053/uptc.2744953X.16418
dc.identifier.eissn.none.fl_str_mv	2744-953X
dc.identifier.url.none.fl_str_mv	https://doi.org/10.19053/uptc.2744953X.16418
identifier_str_mv	2389-8038 10.19053/uptc.2744953X.16418 2744-953X
url	https://repositorio.uptc.edu.co/handle/001/21808 https://doi.org/10.19053/uptc.2744953X.16418
dc.language.iso.none.fl_str_mv
language_invalid_str_mv
dc.relation.references.none.fl_str_mv	Werner SC. Classification of Thyroid Disease [Internet]. 1969 [cited 2023 Mar 28]. Available from: https://pubmed.ncbi.nlm.nih.gov/5814661/ 2.Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Vol. 14, Nature Reviews Endocrinology. Nature Publishing Group; 2018. p. 301–16. 3.Duntas LH TBS. Classification of Thyroid Diseases. Luster M, DuntasLH Warftosky L The Thyroid and Its Diseases . 2018;(Springer.):87-99. 4.Kravets I. Hyperthyroidism: Diagnosis and Treatment [Internet]. Vol. 93. 2016. Available from: www.aafp.org/afp 5.Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Relational stability in the expression of normality, variation, and control of thyroid function. Vol. 7, Frontiers in Endocrinology. Frontiers Media S.A.; 2016. 6.Hoermann R, Midgley JE, Larisch R, Dietrich JW. Homeostatic Control of the Thyroid-Pituitary Axis: Perspectives for Diagnosis and Treatment. ,. Front Endocrinol (Lausanne). 2015;6, 177. 7.Sheehan MT. Biochemical testing of the thyroid: TSH is the best and, oftentimes, only test needed - A review for primary care. Vol. 14, Clinical Medicine and Research. Marshfield Clinic; 2016. p. 83–92. 8.Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016 Oct 1;26(10):1343–421. 9.Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European thyroid association guideline for the management of graves’ hyperthyroidism. Vol. 7, European Thyroid Journal. S. Karger AG; 2018. p. 167–86. 10.Winther KH, Bonnema SJ, Hegedüs L. Is selenium supplementation in autoimmune thyroid diseases justified? Vol. 24, Current Opinion in Endocrinology, Diabetes and Obesity. Lippincott Williams and Wilkins; 2017. p. 348–55. 11.Abbara A, Clarke SA, Brewster R, Simonnard A, Eng PC, Phylactou M, et al. Pharmacodynamic Response to Anti-thyroid Drugs in Graves’ Hyperthyroidism. Front Endocrinol (Lausanne). 2020 May 12;11. 12.Wang M, Yu Y. Therapeutic effects of combination regimens including methimazole on Graves hyperthyroidism: A network meta-analysis of randomized controlled trials. Vol. 26, Endocrine Practice. American Association of Clinical Endocrinologists; 2020. p. 675–87. 13.Burch HB, Cooper DS. Management of graves disease a review. Vol. 314, JAMA - Journal of the American Medical Association. American Medical Association; 2015. p. 2544–54. 14.Knight CL, Cooray SD, Kulkarni J, Borschmann M, Kotowicz M. Thyroidectomy for the treatment of Graves’ thyrotoxicosis in thioamide-induced agranulocytosis and sepsis. Endocrinol Diabetes Metab Case Rep. 2017 Sep 3;2017. 15.Yang J, Zhu YJ, Zhong JJ, Zhang J, Weng WW, Liu ZF, et al. Characteristics of antithyroid drug-induced agranulocytosis in patients with hyperthyroidism: A retrospective analysis of 114 cases in a single institution in China involving 9690 patients referred for radioiodine treatment over 15 years. 16.Prakash I, Nylen ES, Sen S. Lithium as an Alternative Option in Graves Thyrotoxicosis. Case Rep Endocrinol. 2015;2015:1–4. 17.Calissendorff J, Falhammar H. Lugol’s solution and other iodide preparations: perspectives and research directions in Graves’ disease. Endocrine. 2017 Dec 1;58(3):467–73. 18.Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Vol. 7, European Thyroid Journal. S. Karger AG; 2018. p. 55–66. 19.Suwansaksri N, Preechasuk L, Kunavisarut T. Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future. Vol. 2018, International Journal of Endocrinology. Hindawi Limited; 2018.
dc.relation.citationendpage.none.fl_str_mv	16
dc.relation.citationissue.spa.fl_str_mv	2
dc.relation.citationstartpage.none.fl_str_mv	3
dc.relation.citationvolume.spa.fl_str_mv	8
dc.relation.ispartofjournal.spa.fl_str_mv	Salud & Sociedad Uptc
dc.relation.bitstream.none.fl_str_mv	https://revistas.uptc.edu.co/index.php/salud_sociedad/article/download/16418/14686
dc.relation.citationedition.spa.fl_str_mv	Núm. 2 , Año 2023 : Salud y Sociedad Uptc volumen 8 número 2 2023 Calidad del Agua, salud pública y cáncer
dc.rights.none.fl_str_mv	Javier Jaimes Cienfuegos - 2023
dc.rights.uri.none.fl_str_mv	https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.accessrights.none.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.coar.none.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Javier Jaimes Cienfuegos - 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.none.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Subcomité editorial y de evaluación de obras de la Facultad de Ciencias de la Salud Editora Revista Dra. Bibiana Matilde Bernal Gómez
dc.source.none.fl_str_mv	https://revistas.uptc.edu.co/index.php/salud_sociedad/article/view/16418
institution	Universidad Pedagógica y Tecnológica de Colombia
bitstream.url.fl_str_mv	https://repositorio.uptc.edu.co/bitstreams/da7bd928-e4e5-4630-b792-eed0fc1b5ee4/download
bitstream.checksum.fl_str_mv	e14f4ad39a2a8e7428aa1ed959908110
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Institucional UPTC
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1881673893055299584
spelling	Seco Fernández, Ana CarmenJaimes Cienfuegos, JavierJaimes García, Javier2023-08-09 00:00:002026-04-16T17:52:22Z2023-08-09 00:00:002023-08-092389-8038https://repositorio.uptc.edu.co/handle/001/2180810.19053/uptc.2744953X.164182744-953Xhttps://doi.org/10.19053/uptc.2744953X.16418application/pdfSubcomité editorial y de evaluación de obras de la Facultad de Ciencias de la Salud Editora Revista Dra. Bibiana Matilde Bernal GómezJavier Jaimes Cienfuegos - 2023https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.http://purl.org/coar/access_right/c_abf2https://revistas.uptc.edu.co/index.php/salud_sociedad/article/view/16418HipertiroidismoTratamientoEnfermedad de GravesHyperthyroidismTreatmentGraves’ diseaseTratamiento farmacológico del hipertiroidismo actualmenteArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleJournal articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a85Werner SC. Classification of Thyroid Disease [Internet]. 1969 [cited 2023 Mar 28]. Available from: https://pubmed.ncbi.nlm.nih.gov/5814661/ 2.Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Vol. 14, Nature Reviews Endocrinology. Nature Publishing Group; 2018. p. 301–16. 3.Duntas LH TBS. Classification of Thyroid Diseases. Luster M, DuntasLH Warftosky L The Thyroid and Its Diseases . 2018;(Springer.):87-99. 4.Kravets I. Hyperthyroidism: Diagnosis and Treatment [Internet]. Vol. 93. 2016. Available from: www.aafp.org/afp 5.Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Relational stability in the expression of normality, variation, and control of thyroid function. Vol. 7, Frontiers in Endocrinology. Frontiers Media S.A.; 2016. 6.Hoermann R, Midgley JE, Larisch R, Dietrich JW. Homeostatic Control of the Thyroid-Pituitary Axis: Perspectives for Diagnosis and Treatment. ,. Front Endocrinol (Lausanne). 2015;6, 177. 7.Sheehan MT. Biochemical testing of the thyroid: TSH is the best and, oftentimes, only test needed - A review for primary care. Vol. 14, Clinical Medicine and Research. Marshfield Clinic; 2016. p. 83–92. 8.Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016 Oct 1;26(10):1343–421. 9.Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European thyroid association guideline for the management of graves’ hyperthyroidism. Vol. 7, European Thyroid Journal. S. Karger AG; 2018. p. 167–86. 10.Winther KH, Bonnema SJ, Hegedüs L. Is selenium supplementation in autoimmune thyroid diseases justified? Vol. 24, Current Opinion in Endocrinology, Diabetes and Obesity. Lippincott Williams and Wilkins; 2017. p. 348–55. 11.Abbara A, Clarke SA, Brewster R, Simonnard A, Eng PC, Phylactou M, et al. Pharmacodynamic Response to Anti-thyroid Drugs in Graves’ Hyperthyroidism. Front Endocrinol (Lausanne). 2020 May 12;11. 12.Wang M, Yu Y. Therapeutic effects of combination regimens including methimazole on Graves hyperthyroidism: A network meta-analysis of randomized controlled trials. Vol. 26, Endocrine Practice. American Association of Clinical Endocrinologists; 2020. p. 675–87. 13.Burch HB, Cooper DS. Management of graves disease a review. Vol. 314, JAMA - Journal of the American Medical Association. American Medical Association; 2015. p. 2544–54. 14.Knight CL, Cooray SD, Kulkarni J, Borschmann M, Kotowicz M. Thyroidectomy for the treatment of Graves’ thyrotoxicosis in thioamide-induced agranulocytosis and sepsis. Endocrinol Diabetes Metab Case Rep. 2017 Sep 3;2017. 15.Yang J, Zhu YJ, Zhong JJ, Zhang J, Weng WW, Liu ZF, et al. Characteristics of antithyroid drug-induced agranulocytosis in patients with hyperthyroidism: A retrospective analysis of 114 cases in a single institution in China involving 9690 patients referred for radioiodine treatment over 15 years. 16.Prakash I, Nylen ES, Sen S. Lithium as an Alternative Option in Graves Thyrotoxicosis. Case Rep Endocrinol. 2015;2015:1–4. 17.Calissendorff J, Falhammar H. Lugol’s solution and other iodide preparations: perspectives and research directions in Graves’ disease. Endocrine. 2017 Dec 1;58(3):467–73. 18.Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Vol. 7, European Thyroid Journal. S. Karger AG; 2018. p. 55–66. 19.Suwansaksri N, Preechasuk L, Kunavisarut T. Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future. Vol. 2018, International Journal of Endocrinology. Hindawi Limited; 2018.16238Salud & Sociedad Uptchttps://revistas.uptc.edu.co/index.php/salud_sociedad/article/download/16418/14686Núm. 2 , Año 2023 : Salud y Sociedad Uptc volumen 8 número 2 2023 Calidad del Agua, salud pública y cáncerPublicationOREORE.xmltext/xml2716https://repositorio.uptc.edu.co/bitstreams/da7bd928-e4e5-4630-b792-eed0fc1b5ee4/downloade14f4ad39a2a8e7428aa1ed959908110MD51falseAnonymousREAD001/21808oai:repositorio.uptc.edu.co:001/218082026-10-29 14:01:04.976https://creativecommons.org/licenses/by-nc-nd/4.0/metadata.onlyhttps://repositorio.uptc.edu.coRepositorio Institucional UPTCbdigital@metabiblioteca.com

Tratamiento farmacológico del hipertiroidismo actualmente

Publicaciones similares